Icahn School of Medicine at Mount Sinai
New York, 10029, United States
NCT Number: NCT03348683
A randomized, prospective trial will be offered to women admitted to the labor floors at Mount Sinai Medical Center for labor induction.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Phase 2
New York, 10029, United States
Induction of labor is a common obstetric procedure, which is performed to provoke the onset of labor and lead to delivery of the fetus. While some early studies suggested a possible increased rate of cesarean with induction of labor, more recent meta-analyses have shown that induction does not influence this rate. There is data from small randomized studies that demonstrates the effectiveness of propranolol, a non-selective beta-blocker, for induction of labor. This literature suggests a decrease in the amount of time to delivery and a possible reduction in cesarean section rates when propranolol is used in conjunction with oxytocin for induction of labor compared to oxytocin alone.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After induction is started with Foley or misoprostol placement, 30 minutes will pass before administration of the one-time study medication, IV Propanolol.
After induction is started with Foley or misoprostol placement, 30 minutes will pass before administration of IV Saline
Other names: saline
Time frame: average of 24 hours
The time of induction (based on time of foley balloon placement for cervical ripening or misoprostol administration) to the time of delivery of the infant.
Time frame: average of 24 hours
Number of various mode of delivery - count of Vaginal delivery, vacuum assisted vaginal delivery, forceps assisted vaginal delivery, cesarean section
Time frame: average of 24 hours
Time of latent labor defined as <6cm of cervical dilation.
Time frame: average of 24 hours
Composite maternal morbidity score consists of a count of postpartum hemorrhage, transfusion, hysterectomy, placental abruption, chorioamnionitis, shoulder dystocia, episiotomy, higher order laceration, and ICU admission.
The composite score was computed as a score of 1 for any indication of maternal morbidity, that is the participant experienced at least one maternal morbidity, and the components are given equal weights. Participants who had no evidence of the predefined maternal morbidities are subsequently given a score of 0. The minimum is 0 and maximum is 1.
Time frame: 30 minutes from drug administration
Greater than 500cc of blood expelled during a vaginal delivery or greater than 1000cc of blood expelled during a cesarean section
Time frame: 30 minutes from drug administration
Count of fetus with fetal heart rate decelerations within 30 minutes of study drug administration
Time frame: 30 minutes from drug administration
Count of fetus with fetal bradycardia (<110bpm for >10 minutes within 30 minutes of study drug administration)
Time frame: Day 1
Composite neonatal outcome score was for any of the following morbidity: Neonatal Intensive Care Unit (NICU) admission, respiratory support (CPAP, nasal cannula, intubation), culture proven sepsis, radiographically proven intracranial hemorrhage, necrotizing enterocolitis, hypoglycemia (for those infants who had sugar checked), and neonatal death.
The composite score was computed as a score of 1 for any indication of neonatal morbidity - neonates who experienced at least one morbidity and the components are given equal weights. Patients who had no evidence of the predefined neonatal morbidities are subsequently given a score of 0. The minimum is 0 and maximum is 1.
Time frame: Day 1
Neonatal outcome - Number of neonates with hypoglycemia (blood glucose <50).
This population includes only the neonates who had heelsticks to check their blood glucose, which is not a universal practice and was not required by the protocol or IRB. The neonates included were those who met the nursery's risk-based protocol to check blood glucose after birth (ex: infants of diabetic mothers, fetal growth restriction, macrosomia, or symptoms suggestive of hypoglycemia)
Icahn School of Medicine at Mount Sinai
Other
Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients: a Double-blind Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04478942
Female Urogenital Diseases and Pregnancy Complications, Fetal Membranes, Premature Rupture
Madison, Wisconsin, United States
View Trial DetailsNCT02975167
Behavior, Cervical Ripening
Long Beach, California, United States
View Trial DetailsNCT06122168
Induction of Labor Affected Fetus / Newborn, Nulliparity
Ponderano, Biella, Italy
View Trial DetailsNCT03544606
Induction of Labor Affected Fetus / Newborn
Kafr ash Shaykh, Egypt
View Trial Details